David Pendarvis - May 3, 2022 Form 4 Insider Report for RESMED INC (RMD)

Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
May 3, 2022
Transactions value $
-$309,000
Form type
4
Date filed
5/4/2022, 05:03 PM
Previous filing
Apr 5, 2022
Next filing
Jun 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$309K -1.55K -1.39% $200.00 110K May 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.